Stay updated with breaking news from Executive Roy Jakobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ian Walker Philips said it reached a final agreement with the U.S. Justice Department and Food and Drug Administration on terms of a settlement related its Respironics ventilators, and...
By Elena Vardon Royal Philips reached an agreement with the U.S. Food and Drug Administration on the terms of a settlement linked to recall of its...
AMSTERDAM (Reuters) -Dutch health technology company Philips will not sell new devices to treat sleep apnea in the U.S. in the coming years as it works to comply with a settlement with the Food and Drug Administration (FDA) announced on Monday. The agreement followed the recall of millions of breathing devices and ventilators used to treat sleep apnea in 2021 because of concerns that foam used to reduce noise from the devices could degrade and become toxic, carrying potential cancer risks. Philips said it had reached what is known as a consent decree that spells out the improvements it needs...
(Reuters) -Dutch health technology company Philips on Monday modestly increased its full-year targets after beating quarterly earnings expectations but expressed concern over China's drive to become self-sufficient in health-related technologies. The Amsterdam-based group, a former industrial conglomerate that now focuses on medical technology, reported adjusted earnings before interest, taxes and amortisation (EBITA) of 453 million euros ($503.78 million) for the April-June period, above the 394 million euros seen in a company-compiled poll. For the full year, the group expects compar...
Dutch health technology company Philips on Monday slightly raised its full-year targets after posting a bigger-than-expected jump in second-quarter core earnings.